Sodium-glucose co-transporter-2 inhibitor (SGLT2i) treatment and risk of osteomyelitis: A pharmacovigilance study of the FAERS database.
SGLT2抑制劑治療與骨髓炎風險:FAERS資料庫的藥物監察研究。
Front Pharmacol 2023-03-04
Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study.
評估2012年至2017年間美國食品藥物管理局批准的抗糖尿病藥物不良藥物反應報告:一項藥物警戒研究。
Ther Adv Drug Saf 2023-06-20
Risk of Urogenital Bacterial Infection with Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study Using a Claims Database.
使用索引資料庫進行的回顧性世代研究:與鈉葡萄糖共同轉運蛋白-2抑制劑相關的泌尿生殖系細菌感染風險。
Diabetes Ther 2024-07-03
Skin-Related Adverse Reactions Induced by Oral Antidiabetic Drugs-A Review of Literature and Case Reports.
口服抗糖尿病藥物引起的皮膚相關不良反應-文獻與案例報告的綜述。
Pharmaceuticals (Basel) 2024-07-27
Comparison over Time of Adverse Drug Reactions in Diabetes Patients Treated with Sodium-Glucose Cotransporter 2 Inhibitors.
糖尿病患者使用鈉-葡萄糖共轉運蛋白 2 抑制劑的藥物不良反應隨時間的比較。
Kobe J Med Sci 2024-08-07
Drugs with a negative impact on cognitive functions (part 3): antibacterial agents in patients with chronic kidney disease.
對認知功能有負面影響的藥物(第三部分):慢性腎病患者中的抗菌劑。
Clin Kidney J 2024-08-08
Acute kidney injury is associated with abnormal cefepime exposure among critically ill children and young adults.
急性腎損傷與重症兒童及年輕成人中異常的 cefepime 暴露相關。
Pediatr Nephrol 2024-08-16
Effect of chronic kidney disease on adverse drug reactions to anti-tubercular treatment: a retrospective cohort study.
慢性腎病對抗結核治療不良藥物反應的影響:一項回顧性隊列研究。
Ren Fail 2024-08-21